Table 5.
Characteristics of non-CAD patients and CAD patients according to the common genotypes (Data are means ± SD)
|
TT |
p value |
TC + CC |
p value | |||
|---|---|---|---|---|---|---|
| Non-CAD patients | CAD patients | Non-CAD patients | CAD patients | |||
| Age (years) | 63.0 ± 10.9 | 62. 6 ± 9.5 | 0.713 | 63.5 ± 10.3 | 62.5 ± 9.4 | 0.685 |
| TG (mmol/L) | 1.61 ± 0.86 | 2.29 ± 1.62* | 0.000 | 2.24 ± 1.90 | 2.01 ± 1.39 | 0.790 |
| TC (mmol/L) | 4.45 ± 0.91 | 4.49 ± 1.16 | 0.615 | 4.65 ± 1.47 | 4.54 ± 1.08 | 0.372 |
| LDL-C (mmol/L) | 2.32 ± 0.90 | 2.17 ± 1.09 | 0.204 | 2.44 ± 1.01 | 2.41 ± 1.04 | 0.781 |
| HDL-C (mmol/L) | 1.20 ± 0.30 | 1.12 ± 0.41* | 0.001 | 1.32 ± 0.35 | 1.11 ± 0.27* | 0.030 |
| ApoAI (g/L) | 1.20 ± 0.13 | 1.19 ± 0.15 | 0.481 | 1.23 ± 0.15 | 1.18 ± 0.19 | 0.331 |
| ApoB (g/L) | 0.87 ± 0.18 | 0.93 ± 0.28 | 0.203 | 0.90 ± 0.29 | 0.94 ± 0.24 | 0.366 |
| LP(a) (g/L) | 105 ± 99 | 108 ± 77 | 0.052 | 97 ± 123 | 95 ± 53 | 0.281 |
Note:
*
p < 0.05 vs control group.
Abbreviations: ApoAI, apolipoprotein AI; ApoB, apolipoprotein B; CAD, coronary artery disease; LDL-C, low-density lipoprotein cholesterol; LP(a), lipoprotein(a);HDL-C, high-density lipoprotein cholesterol; SD, standard deviation; TC, total cholesterol; TG, triglycerides.